Evidence map›Paper›PMID 39421186›Full record

ArticleEcancermedicalscience2024

Craniofacial primary well-differentiated low-grade central osteosarcoma in a paediatric patient: a case report.

Pablo Horacio Cázares-Vázquez, Richael Antonio Silva-Suárez, Franco Andrés Ortiz-Álvarez, Guillermo Joaquín Guillermo Gaytán-Fernández, Gilberto Flores-Vargas, Nicolás Padilla-Raygoza

Abstract readCase Reports
In one paragraph

Article in Ecancermedicalscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pablo Horacio Cázares-VázquezDepartment of General Surgery, Hospital General León, Institute of Public Health from Guanajuato State, León CP 37672, Mexico.
Richael Antonio Silva-SuárezDepartment of Maxillofacial Surgery, Hospital General León, Institute of Public Health from Guanajuato State, León CP 37672, Mexico.
Franco Andrés Ortiz-ÁlvarezDepartment of Maxillofacial Surgery, Hospital General León, Institute of Public Health from Guanajuato State, León CP 37672, Mexico.
Guillermo Joaquín Guillermo Gaytán-FernándezDepartment of Paediatric Oncology, Hospital General León, Institute of Public Health from Guanajuato State, León CP 37672, Mexico.
Gilberto Flores-VargasDepartment of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato CP36000, Mexico.
Nicolás Padilla-RaygozaDepartment of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato CP36000, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma is a primary malignant tumour that accounts for less than 1% of cancers diagnosed annually in the United States and 3% of all cancers in paediatric patients. Surgical treatment and adjuvant chemotherapy are essential to improve short- and long-term survival. In this report, we present the case of an 11-month-old female patient referred to the first level of care for a suspected tumour in the left orbit, who underwent biopsy and tumour resection surgery by the maxillofacial surgery service and underwent adjuvant chemotherapy in a specialised centre. Timely detection of cancer in the paediatric population, as well as multidisciplinary management and close surveillance, improves the survival and quality of life of patients.

Indexed as

chemotherapyosteosarcomapaediatric agesurgery

Identifiers

PMID39421186
PMCPMC11484673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.